Avior Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Avior Wealth Management's EW Position: Q1 2025 in Review
Avior Wealth Management sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 493 shares — an estimated $36.5K sold.
Avior Wealth Management first reported a position in EW in Q2 2016 and held it in 26 quarters. The position peaked at $132K in Q1 2024. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.
- Avior Wealth Management reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
- Avior Wealth Management sold 493 Edwards Lifesciences shares in Q1 2025, an estimated $36.5K.
- Avior Wealth Management first reported a position in Edwards Lifesciences in Q2 2016 and held it in 26 quarters.
- Avior Wealth Management's Edwards Lifesciences position peaked at $132K in Q1 2024.
- 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.
Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.